These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30960254)

  • 101. Noncovalent complexation of amphotericin-B with Poly(α-glutamic acid).
    Mohamed-Ahmed AH; Les KA; Seifert K; Croft SL; Brocchini S
    Mol Pharm; 2013 Mar; 10(3):940-50. PubMed ID: 23234235
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Incorporation and release behavior of amitriptylene in core-shell-corona type triblock copolymer micelles.
    Bastakoti BP; Guragain S; Yokoyama Y; Yusa S; Nakashima K
    Colloids Surf B Biointerfaces; 2011 Dec; 88(2):734-40. PubMed ID: 21890331
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Encapsulation and release of Amphotericin B from an ABC triblock fluorous copolymer.
    Jee JP; McCoy A; Mecozzi S
    Pharm Res; 2012 Jan; 29(1):69-82. PubMed ID: 21739321
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles.
    Xiao K; Li Y; Luo J; Lee JS; Xiao W; Gonik AM; Agarwal RG; Lam KS
    Biomaterials; 2011 May; 32(13):3435-46. PubMed ID: 21295849
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration.
    Hirn S; Semmler-Behnke M; Schleh C; Wenk A; Lipka J; Schäffler M; Takenaka S; Möller W; Schmid G; Simon U; Kreyling WG
    Eur J Pharm Biopharm; 2011 Apr; 77(3):407-16. PubMed ID: 21195759
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
    Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
    J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Development of amphotericin B loaded polymersomes based on (PEG)(3)-PLA co-polymers: Factors affecting size and in vitro evaluation.
    Jain JP; Kumar N
    Eur J Pharm Sci; 2010 Aug; 40(5):456-65. PubMed ID: 20580669
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Enhanced stability of PEG-block-poly(N-hexyl stearate l-aspartamide) micelles in the presence of serum proteins.
    Diezi TA; Bae Y; Kwon GS
    Mol Pharm; 2010 Aug; 7(4):1355-60. PubMed ID: 20575526
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Tumoral acidic pH-responsive MPEG-poly(beta-amino ester) polymeric micelles for cancer targeting therapy.
    Min KH; Kim JH; Bae SM; Shin H; Kim MS; Park S; Lee H; Park RW; Kim IS; Kim K; Kwon IC; Jeong SY; Lee DS
    J Control Release; 2010 Jun; 144(2):259-66. PubMed ID: 20188131
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles.
    He C; Hu Y; Yin L; Tang C; Yin C
    Biomaterials; 2010 May; 31(13):3657-66. PubMed ID: 20138662
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles.
    Ren T; Xu N; Cao C; Yuan W; Yu X; Chen J; Ren J
    J Biomater Sci Polym Ed; 2009; 20(10):1369-80. PubMed ID: 19622277
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Effect of aggregation state on the toxicity of different amphotericin B preparations.
    Espada R; Valdespina S; Alfonso C; Rivas G; Ballesteros MP; Torrado JJ
    Int J Pharm; 2008 Sep; 361(1-2):64-9. PubMed ID: 18599228
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles.
    Nahar M; Mishra D; Dubey V; Jain NK
    Nanomedicine; 2008 Sep; 4(3):252-61. PubMed ID: 18502187
    [TBL] [Abstract][Full Text] [Related]  

  • 114. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
    J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
    Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
    J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Amphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasis.
    Sánchez-Brunete JA; Dea MA; Rama S; Bolás F; Alunda JM; Torrado-Santiago S; Torrado JJ
    J Drug Target; 2004; 12(7):453-60. PubMed ID: 15621670
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length.
    Adams ML; Kwon GS
    J Control Release; 2003 Feb; 87(1-3):23-32. PubMed ID: 12618020
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Cationic polymer based gene delivery systems.
    De Smedt SC; Demeester J; Hennink WE
    Pharm Res; 2000 Feb; 17(2):113-26. PubMed ID: 10751024
    [TBL] [Abstract][Full Text] [Related]  

  • 119. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery.
    Ogris M; Brunner S; Schüller S; Kircheis R; Wagner E
    Gene Ther; 1999 Apr; 6(4):595-605. PubMed ID: 10476219
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Lipid-based formulations of amphotericin B.
    Swenson CE; Bolcsak LE; Perkins WR; Janoff AS
    J Antimicrob Chemother; 1995 May; 35(5):709-13. PubMed ID: 7592188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.